Hironaka Kawasaki

Serum hepatocyte growth factor levels in liver diseases: Clinical implications

Goshi Shiota, Jun‐ichi Okano, Hironaka Kawasaki et al. · Hepatology · 1995 · 206 citations

Immunology, Pathology, Serum Hgf +20

Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma

Masahiko Koda, Yoshikazu Murawaki, Akeri Mitsuda et al. · Cancer · 2001 · 151 citations

Serum Type Iii Procollagen Peptide, Type Iv Collagen 7S Domain, Central Triple–Helix of Type Iv Collagen and Tissue Inhibitor of Metalloproteinases in Patients With Chronic Viral Liver Disease: Relationship to Liver Histology

Yoshikazu Murawaki, Yujiro Ikuta, Masahiko Koda et al. · Hepatology · 1994 · 127 citations

Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease

Y Murawaki, Yujiro Ikuta, Youko Idobe et al. · Journal of Hepatology · 1997 · 86 citations

Hepatology, Liver Physiology, Chronic Liver Disease +12

Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C

Yoshikazu Murawaki, Yujiro Ikuta, Kinya Okamoto et al. · Journal of Gastroenterology · 2001 · 84 citations

Connective Tissue Turnover, Hepatology, Hepatitis C +10